Dar Zavain
SEC insider (Form 3/4/5 filer). CIK 0001852075. Director at RECURSION PHARMACEUTICALS, INC. (RXRX). 11 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in SALT LAKE CITY, UT.
Companies Dar Zavain has filed insider reports for
- RECURSION PHARMACEUTICALS, INC. (RXRX): Director
Dar Zavain
CIK: 0001852075
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RECURSION PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Oct 1, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect4.6K shares- - Jul 1, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect5.1K shares- - Jun 17, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect88.4K shares- - Apr 1, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect4.9K shares- - Jan 2, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect3.6K shares- - Oct 1, 2025RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect2.9K shares- - Jul 1, 2025RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect2.9K shares- - Jun 18, 2025RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect22K shares- - Apr 1, 2025RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect2.7K shares- - Jan 2, 2025RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect1.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 4,607 | - | $0 | Direct |
| Jul 1, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 5,109 | - | $0 | Direct |
| Jun 17, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 88,424 | - | $0 | Direct |
| Apr 1, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 4,902 | - | $0 | Direct |
| Jan 2, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 3,571 | - | $0 | Direct |
| Oct 1, 2025 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 2,941 | - | - | Direct |
| Jul 1, 2025 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 2,924 | - | - | Direct |
| Jun 18, 2025 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 22,016 | - | - | Direct |
| Apr 1, 2025 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 2,745 | - | - | Direct |
| Jan 2, 2025 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 1,907 | - | $0 | Direct |
1-10 of 11 transactions